Global NGS Sample Preparation Market Insights, Size and Growth Forecast To 2027

Global NGS Sample Preparation Market by Product (Reagent & Consumables, and NGS Workstations), By Workflow (Library Preparation [DNA, RNA], Target Enrichment (Targeted Sequencing, Whole Exome Sequencing and Others) and Quality Control), By Technology (Sequencing By Synthesis (Sbs), Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing (Smrt), Nanopore Sequencing and Others), By Application (Diagonsis(Infectious Disease, Cancer Diagnostics and Reproductive Health Diagnostics), Drug Discovery, Agricultural & Animal Research, and Others),By End-User(Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies and Others) and By Region (North America, Europe, Asia Pacific, South America, and Middle East & Africa)

Published: Aug-2020	Report ID: SEMI2001	Pages: 1 - 250	Formats^*:
Category : Semiconductor and Electronics

Global NGS Sample Preparation market expected to propel by the growing adoption of NGS sample preparation in developing innovative diagnostic tools and tests and development of precision & personalized medicines. Global NGS Sample Preparation market predicted to grow with a noteworthy rate during the forecast period, 2020-2027, on account of the rise in the incidence of diseases like cancer and the growing use of NGS for diagnostic purposes in cancer and management or treatment of disease. Additionally, the advancements in NSG platforms, declining cost of sequencing, and NSG platforms and improving regulatory for NSG based diagnostic tests. Moreover, the evolution of integrated and automated informatics and mechanical protocols based NGS sample preparation as it enhances sequencing speed & capacity, and sample tracking will lead to the robust growth of the NGS sample preparation market in the future time.

Furthermore, the growing R&D activities for developing therapies utilized in the treatment of genetic diseases across the developing and developed countries will accelerate the growth of the NGS sample preparation industry. The application of next-generation sequencing technology help in deciphering human diseases, especially in cancer. The rapid development of next-generation sequencing (NGS) has greatly reduced the cost of sequencing and achieved high throughput, which allows obtaining the sequence of the entire genome and all the genome information of those patients who are clinically diagnosed. In addition, the growing usage of NGS tools design therapies according to the nature of the disease, which helped the pharmaceutical and biopharmaceutical companies, thereby boosting the growth of the NGS sample preparation industry.

Product Overview in the Global NGS Sample Preparation Market

Based on the product, the global NGS Sample Preparation market categorized into Reagent & Consumables and NGS Workstations. The Reagent & Consumables segment likely to lead the market by 2027, as they are widespread throughout the sample preparation process and decreasing cost of sequencing, NGS platforms, and the growing applications of NGS in various fields such as drug and discovery, diagnostics, agro-genomics, and animal research, etc.

Technology Overview in the Global NGS Sample Preparation market

Based on technology, the global NGS Sample Preparation market classified into Sequencing by Synthesis (SBS), Ion Semiconductor Sequencing, Single-Molecule Real-Time Sequencing (Smrt), Nanopore Sequencing, and Others. The sequencing by synthesis (SBS) segment accounted for a higher market share in 2019. It will continue to dominate the market by 2027, owing it is cost-effective, scalable, high yield of the sample, and are simple to operate.

Workflow Overview in the Global NGS Sample Preparation market

Based on workflow, the global NGS Sample Preparation market classified into Library Preparation [DNA, RNA], Target Enrichment (Targeted Sequencing, Whole Exome Sequencing, and Others), and Quality Control. Target Enrichment will be the fastest-growing segment, attributable to it help in providing a detailed view of the genome, including coding and non-coding genomic regions, and helps to provide comprehensive approaches to examine the impact of DNA sequence variations on human diversity.

Application Overview in the Global NGS Sample Preparation Market

Based on application, the global NGS Sample Preparation market categorized into Diagnosis (Infectious Disease, Cancer Diagnostics, and Reproductive Health Diagnostics), Drug Discovery, Agricultural & Animal Research, and Others. The Diagnosis segment projected to lead the market due to the rising number of new cancer cases across the world, and growing focus of key market players on developing NGS-based products & services for cancer and NIPT.

End-User Overview in the Global NGS Sample Preparation Market

Based on end-user, the global NGS Sample Preparation market categorized into Academic Institutes & Research Centers, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Others. Academic Institutes & Research Centers segment estimated to dominate the market by 2027 on account of the extensive experiments and studies performed in research and academic centers to develop novel therapies.

Hospitals & Clinics segment will drive owing to the hospitals providing NGS for diagnosis of immune disorders, infectious diseases, non-invasive prenatal diagnosis, and in the detection of human hereditary disorders.

Regional Overview in the Global NGS Sample Preparation Market

By geography, the Global NGS Sample Preparation Market segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is anticipated to witness a higher growth rate by 2027, owing to the presence of high R&D investment, technologically advanced healthcare research framework, simultaneous developments of personalized medicine and companion diagnostics along with the presence of key players in these regions.

Global NGS Sample Preparation Market: Competitive Landscape

Companies such as Illumina Inc., Thermo Fisher Scientific, QIAGEN N.V., Agilent Technologies, Inc., Beckman Coulter, Becton, Dickinson and Company, Pacific Biosciences of California, PerkinElmer Inc., F. Hoffmann-La Roche, New England Biolabs, Inc., and NuGEN Technologies, Inc. are the key players in the Global NGS Sample Preparation Market.

1. Research Strategic Development

1.1. Market Modelling
1.2. Product Analysis
1.3. Market Trend and Economic Factors Analysis
1.4. Market Segmental Analysis
1.5. Geographical Mapping
1.6. Country Wise Segregation

2. Research Methodology

2.1. Identification of Target Market
2.2. Data Acquisition
2.3. Refining of Data/ Data Transformations
2.4. Data Validation through Primary Techniques
2.5. Exploratory Data Analysis
2.6. Graphical Techniques/Analysis
2.7. Quantitative Techniques/Analysis
2.8. Visual Result/Presentation

3. Executive Summary

4. Market Insights

4.1. Economic Factor Analysis
4.1.1. Drivers
4.1.2. Trends
4.1.3. Opportunities
4.1.4. Challenges
4.2. Technological Landscape
4.3. Competitors & Product Analysis
4.4. Regulatory Framework
4.5. Company market share analysis, 2019
4.6. Porterâ€™s Five forces analysis
4.7. New Investment Analysis
4.8. PESTEL Analysis

5. Global NGS Sample Preparation Market Overview

5.1. Market Size & Forecast, 2016-2027
5.1.1. Demand
5.1.1.1. By Value (USD Million)
5.2. Market Share & Forecast, 2016-2027
5.2.1. By Product
5.2.1.1. Reagent & Consumables
5.2.1.2. Workstations
5.2.2. By Workflow
5.2.2.1. Library Preparation
5.2.2.1.1. DNA
5.2.2.1.2. RNA
5.2.2.2. Target Enrichment
5.2.2.2.1. Targeted Sequencing
5.2.2.2.2. Whole Exome Sequencing
5.2.2.2.3. Others
5.2.2.3. Quality Control
5.2.3. By Technology
5.2.3.1. Sequencing By Synthesis (Sbs)
5.2.3.2. Ion Semiconductor Sequencing
5.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
5.2.3.4. Nanopore Sequencing
5.2.3.5. Others
5.2.4. By Application
5.2.4.1. Diagnosis
5.2.4.1.1. Infectious Disease
5.2.4.1.2. Cancer Diagnostics
5.2.4.1.3. Reproductive Health Diagnostics
5.2.4.2. Drug Discovery,
5.2.4.3. Agricultural & Animal Research
5.2.4.4. Others
5.2.5. By End-User
5.2.5.1. Academic Institutes & Research Centers
5.2.5.2. Hospitals & Clinics
5.2.5.3. Pharmaceutical & Biotechnology Companies
5.2.5.4. Others
5.2.6. By Region
5.2.6.1. North America
5.2.6.2. Europe
5.2.6.3. Asia Pacific
5.2.6.4. South America
5.2.6.5. Middle East & Africa

6. North America NGS Sample Preparation Market Overview

6.1. North America NGS Sample Preparation Market Size & Forecast, 2016-2027
6.1.1. Demand
6.1.1.1. By Value (USD Million)
6.2. North America NGS Sample Preparation Market Share & Forecast, 2016-2027
6.2.1. By Product
6.2.1.1. Reagent & Consumables
6.2.1.2. Workstations
6.2.2. By Workflow
6.2.2.1. Library Preparation
6.2.2.1.1. DNA
6.2.2.1.2. RNA
6.2.2.2. Target Enrichment
6.2.2.2.1. Targeted Sequencing
6.2.2.2.2. Whole Exome Sequencing
6.2.2.2.3. Others
6.2.2.3. Quality Control
6.2.3. By Technology
6.2.3.1. Sequencing By Synthesis (Sbs)
6.2.3.2. Ion Semiconductor Sequencing
6.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
6.2.3.4. Nanopore Sequencing
6.2.3.5. Others
6.2.4. By Application
6.2.4.1. Diagnosis
6.2.4.1.1. Infectious Disease
6.2.4.1.2. Cancer Diagnostics
6.2.4.1.3. Reproductive Health Diagnostics
6.2.4.2. Drug Discovery,
6.2.4.3. Agricultural & Animal Research
6.2.4.4. Others
6.2.5. By End-User
6.2.5.1. Academic Institutes & Research Centers
6.2.5.2. Hospitals & Clinics
6.2.5.3. Pharmaceutical & Biotechnology Companies
6.2.5.4. Others
6.2.6. By Country
6.2.6.1. US
6.2.6.2. Canada
6.2.6.3. Mexico
6.2.7. Company Market Share (Top 3-5)
6.2.8. Economic Impact Study on North America NGS Sample Preparation Market

7. Europe NGS Sample Preparation Market Overview

7.1. Europe NGS Sample Preparation Market Size & Forecast, 2016-2027
7.1.1. Demand
7.1.1.1. By Value (USD Million)
7.2. Europe NGS Sample Preparation Market Share & Forecast, 2016-2027
7.2.1. By Product
7.2.1.1. Reagent & Consumables
7.2.1.2. Workstations
7.2.2. By Workflow
7.2.2.1. Library Preparation
7.2.2.1.1. DNA
7.2.2.1.2. RNA
7.2.2.2. Target Enrichment
7.2.2.2.1. Targeted Sequencing
7.2.2.2.2. Whole Exome Sequencing
7.2.2.2.3. Others
7.2.2.3. Quality Control
7.2.3. By Technology
7.2.3.1. Sequencing By Synthesis (Sbs)
7.2.3.2. Ion Semiconductor Sequencing
7.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
7.2.3.4. Nanopore Sequencing
7.2.3.5. Others
7.2.4. By Application
7.2.4.1. Diagnosis
7.2.4.1.1. Infectious Disease
7.2.4.1.2. Cancer Diagnostics
7.2.4.1.3. Reproductive Health Diagnostics
7.2.4.2. Drug Discovery,
7.2.4.3. Agricultural & Animal Research
7.2.4.4. Others
7.2.5. By End-User
7.2.5.1. Academic Institutes & Research Centers
7.2.5.2. Hospitals & Clinics
7.2.5.3. Pharmaceutical & Biotechnology Companies
7.2.5.4. Others
7.2.6. By Country
7.2.6.1. Germany
7.2.6.2. UK
7.2.6.3. France
7.2.6.4. Italy
7.2.6.5. Rest of Europe
7.2.7. Company Market Share (Top 3-5)
7.2.8. Economic Impact Study on Europe NGS Sample Preparation Market

8. Asia Pacific NGS Sample Preparation Market Overview

8.1. Asia Pacific NGS Sample Preparation Market Size & Forecast, 2016-2027
8.1.1. Demand
8.1.1.1. By Value (USD Million)
8.2. Asia Pacific NGS Sample Preparation Market Share & Forecast, 2016-2027
8.2.1. By Product
8.2.1.1. Reagent & Consumables
8.2.1.2. Workstations
8.2.2. By Workflow
8.2.2.1. Library Preparation
8.2.2.1.1. DNA
8.2.2.1.2. RNA
8.2.2.2. Target Enrichment
8.2.2.2.1. Targeted Sequencing
8.2.2.2.2. Whole Exome Sequencing
8.2.2.2.3. Others
8.2.2.3. Quality Control
8.2.3. By Technology
8.2.3.1. Sequencing By Synthesis (Sbs)
8.2.3.2. Ion Semiconductor Sequencing
8.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
8.2.3.4. Nanopore Sequencing
8.2.3.5. Others
8.2.4. By Application
8.2.4.1. Diagnosis
8.2.4.1.1. Infectious Disease
8.2.4.1.2. Cancer Diagnostics
8.2.4.1.3. Reproductive Health Diagnostics
8.2.4.2. Drug Discovery,
8.2.4.3. Agricultural & Animal Research
8.2.4.4. Others
8.2.5. By End-User
8.2.5.1. Academic Institutes & Research Centers
8.2.5.2. Hospitals & Clinics
8.2.5.3. Pharmaceutical & Biotechnology Companies
8.2.5.4. Others
8.2.6. By Country
8.2.6.1. China
8.2.6.2. India
8.2.6.3. Japan
8.2.6.4. Australia
8.2.6.5. Rest of Asia Pacific
8.2.7. Company Market Share (Top 3-5)
8.2.8. Economic Impact Study on Asia Pacific NGS Sample Preparation Market

9. South America NGS Sample Preparation Market Overview

9.1. South America NGS Sample Preparation Market Size & Forecast, 2016-2027
9.1.1. Demand
9.1.1.1. By Value (USD Million)
9.2. South America NGS Sample Preparation Market Share & Forecast, 2016-2027
9.2.1. By Product
9.2.1.1. Reagent & Consumables
9.2.1.2. Workstations
9.2.2. By Workflow
9.2.2.1. Library Preparation
9.2.2.1.1. DNA
9.2.2.1.2. RNA
9.2.2.2. Target Enrichment
9.2.2.2.1. Targeted Sequencing
9.2.2.2.2. Whole Exome Sequencing
9.2.2.2.3. Others
9.2.2.3. Quality Control
9.2.3. By Technology
9.2.3.1. Sequencing By Synthesis (Sbs)
9.2.3.2. Ion Semiconductor Sequencing
9.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
9.2.3.4. Nanopore Sequencing
9.2.3.5. Others
9.2.4. By Application
9.2.4.1. Diagnosis
9.2.4.1.1. Infectious Disease
9.2.4.1.2. Cancer Diagnostics
9.2.4.1.3. Reproductive Health Diagnostics
9.2.4.2. Drug Discovery,
9.2.4.3. Agricultural & Animal Research
9.2.4.4. Others
9.2.5. By End-User
9.2.5.1. Academic Institutes & Research Centers
9.2.5.2. Hospitals & Clinics
9.2.5.3. Pharmaceutical & Biotechnology Companies
9.2.5.4. Others
9.2.6. By Country
9.2.6.1. Brazil
9.2.6.2. Argentina
9.2.6.3. Rest of South America
9.2.7. Company Market Share (Top 3-5)
9.2.8. Economic Impact Study on South America NGS Sample Preparation Market

10. Middle East & Africa NGS Sample Preparation Market Overview

10.1. Middle East & Africa NGS Sample Preparation Market Size & Forecast, 2016-2027
10.1.1. Demand
10.1.1.1. By Value (USD Million)
10.2. Middle East & Africa NGS Sample Preparation Market Share & Forecast, 2016-2027
10.2.1. By Product
10.2.1.1. Reagent & Consumables
10.2.1.2. Workstations
10.2.2. By Workflow
10.2.2.1. Library Preparation
10.2.2.1.1. DNA
10.2.2.1.2. RNA
10.2.2.2. Target Enrichment
10.2.2.2.1. Targeted Sequencing
10.2.2.2.2. Whole Exome Sequencing
10.2.2.2.3. Others
10.2.2.3. Quality Control
10.2.3. By Technology
10.2.3.1. Sequencing By Synthesis (Sbs)
10.2.3.2. Ion Semiconductor Sequencing
10.2.3.3. Single-Molecule Real-Time Sequencing (Smrt)
10.2.3.4. Nanopore Sequencing
10.2.3.5. Others
10.2.4. By Application
10.2.4.1. Diagnosis
10.2.4.1.1. Infectious Disease
10.2.4.1.2. Cancer Diagnostics
10.2.4.1.3. Reproductive Health Diagnostics
10.2.4.2. Drug Discovery,
10.2.4.3. Agricultural & Animal Research
10.2.4.4. Others
10.2.5. By End-User
10.2.5.1. Academic Institutes & Research Centers
10.2.5.2. Hospitals & Clinics
10.2.5.3. Pharmaceutical & Biotechnology Companies
10.2.5.4. Others
10.2.6. By Country
10.2.6.1. Saudi Arabia
10.2.6.2. UAE
10.2.6.3. South Africa
10.2.6.4. Rest of Middle East & Africa
10.2.7. Company Market Share (Top 3-5)
10.2.8. Economic Impact Study on Middle East & Africa NGS Sample Preparation Market

11. Competitor Analysis

11.1. Company Description
11.2. Financial Analysis
11.3. Key Products
11.4. Key Management Personnel
11.5. Contact Address
11.6. SWOT Analysis
11.7. Company Profile
11.7.1. Illumina Inc.
11.7.2. Thermo Fisher Scientific
11.7.3. QIAGEN N.V.
11.7.4. Agilent Technologies, Inc.
11.7.5. Beckman Coulter
11.7.6. Becton
11.7.7. Dickinson and Company
11.7.8. Pacific Biosciences of California
11.7.9. PerkinElmer Inc.
11.7.10. F. Hoffmann-La Roche
11.7.11. New England Biolabs, Inc.
11.7.12. NuGEN Technologies
11.7.13. Other Prominent Players

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1